A Scoping Review of Non-Medical and Extra-Medical Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Rebekah BrennanMayyada WazaifyMarie Claire Van Hout Review Article Open access 30 July 2021 Pages: 917 - 928
NSAIDs and COVID-19: A Systematic Review and Meta-analysis Nicholas MoorePauline Bosco-LevyCécile Droz-Perroteau Systematic Review 02 August 2021 Pages: 929 - 938
Augmenting Product Defect Surveillance Through Web Crawling and Machine Learning in Singapore Pei San AngDesmond Chun Hwee TeoJalene Wang Woon Poh Original Research Article 19 June 2021 Pages: 939 - 948
Bayesian Modeling for the Detection of Adverse Events Underreporting in Clinical Trials Yves BarmazTimothé Ménard Original Research Article 14 July 2021 Pages: 949 - 955
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance Annamaria MascoloCristina ScavoneAnnalisa Capuano Original Research Article Open access 18 June 2021 Pages: 957 - 971
Is There an Increased Risk of Hepatotoxicity with Metamizole? A Comparative Cohort Study in Incident Users Karin HedenmalmAlexandra PacurariuRob Flynn Original Research Article 17 July 2021 Pages: 973 - 985
Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020 Elena RoccaOskar GauffinBirgitta Grundmark Original Research Article Open access 10 August 2021 Pages: 987 - 998
Study of Natural Products Adverse Reactions (SONAR) in Adults with Mental Health Conditions: A Cross-Sectional Study Liliane ZorzelaBaljit KhambaSunita Vohra Original Research Article 28 July 2021 Pages: 999 - 1006
Comment on: "Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)" Alain BraillonMarine Martin Letter to the Editor 29 July 2021 Pages: 1007 - 1009
Authors’ Reply to Braillon and Martin’s Comment on “Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)” Priya BahriDaniel R. MoralesSabine M. J. M. Straus Letter to the Editor 29 July 2021 Pages: 1011 - 1013
Correction to: Provision and Need for Medicine Information in Asia and Africa: A Scoping Review of the Literature Pitchaya NualdaisriSarah A. CorlettJanet Krska Correction 13 July 2021 Pages: 1015 - 1015